Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al.

prindi

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

autor

Jueliger, Simone

Lyons, John

Cannito, Sara

Pata, Illar

Pata, Pille

Školnaja, Marianna

vastutusandmed

Simone Jueliger, John Lyons, Sara Cannito, Illar Pata, Pille Pata, Marianna Shkolnaya, Oriana Lo Re, Marion Peyrou, Francesc Villarroya, Valerio Pazienza, Francesca Rappa, Francesco Cappello, Mohammad Azab, Pietro Taverna, and Manlio Vinciguerra

allikas

Epigenetics

kirjastus/väljaandja

Taylor & Francis

ajakirja aastakäik number kuu

vol. 11, 10

ilmumisaasta

2016

leheküljed

p. 709-720 : ill

leitav

https://doi.org/10.1080/15592294.2016.1214781

märksõna

maksavähk

DNA metüülimine

histoonid

võtmesõna

decitabine

DNA methylation

guadecitabine

hepatocellular carcinoma (HCC)

histone macroH2A1

steatohepatitis

ISSN

1559-2294

märkused

Bibliogr.: 45 ref

Open Access

teaduspublikatsioon

klassifikaator

1.1

Scopus

Journal metrics at Scopus

Article at Scopus

WOS

Journal metrics at WOS

Article at WOS

kategooria (üld)

Biochemistry, genetics and molecular biology

kategooria (alam)

Biochemistry, genetics and molecular biology. Cancer research

Biochemistry, genetics and molecular biology. Molecular biology

kvartiil

TTÜ struktuuriüksus

geenitehnoloogia instituut

keel

inglise

Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma // Epigenetics (2016) vol. 11, 10, p. 709-720 : ill. https://doi.org/10.1080/15592294.2016.1214781